Person: Dr André Musy

Karimah Es Sabar

Karimah Es Sabar has been appointed executive director of BC Biotech, an association representing the province’s biotechnology industry. Es Sabar was most recently VP and COO of Medsurge Medical Inc. Prior to that, she was founder and managing director of SAL Healthcare Ltd, a marketing, distribution and consulting firm in Nairobi Kenya. Es Sabar holds…

Dr André Musy

Dr André Musy has been appointed DG of Ouranos, the research institute of Hydro-Québec. Musy comes to Ouranos from the École Polytechnique Fédérale de Lausanne (EPFL). His experience in hydrology, the environment and land and water use is well suited to Ouranos’ two-pronged research program of climate science/hydrology and impacts and adaptation strategies. Musy holds…

Dr Trevor Hawkins

Dr Trevor Hawkins has been appointed to the newly created position of chief science and technology officer at MDS Inc. Hawkins joins MDS during a period of transition in the executive suite (see below). He was previously president of the molecular diagnostics business unit at GE Healthcare and senior VP development and new business initiatives…

Stephen DeFalco

Stephen DeFalco has been appointed COO of MDS Inc and will become president and CEO when he replaces retiring John Rogers at the end of 2005. Defalco is chair and CEO of US Genomics, a firm he founded in 2003. Prior to that he was president of PerkinElmer Instruments and senior VP of PerkinElmer Inc.…

Gregory McKee

Gregory McKee has been appointed president and CEO of Victoria-based Stressgen Biotechnologies Corp, replacing Dan Korpolinski. The move comes after Stressgen withdrew its preliminary prospectus for a common share offering and a decision to sell its bioreagents business to a US firm (see New Briefs). Prior to his appointment, McKee was Stressgen’s chief financial officer…

Dr Alan Bernstein

Dr Alan Bernstein has been re-appointed to a second five-year term as president of the Canadian Institutes of Health Research. The appointment is subject to review by the Standing Committee on Health….

Paul Johnston

Paul Johnston has been appointed president and CEO of Precarn Inc, replacing Dr Anthony Eyton who is taking early retirement. Johnston is a 15-year veteran of Precarn, serving as its VP operations since 1997. Prior to that, he was network manager at the Institute for Robotics and Intelligent Systems, a Network of Centres of Excellence…

Dr Peter Munsche

Dr Peter Munsche is stepping down as assistant VP, technology transfer at the Univ of Toronto after 17 years. Munsche took up the position after serving for six years (1982-88) as executive director of the Canadian Institute for Advanced Research. While at U of T, he was founding chair of the Canadian University Intellectual Property…